North Africa Generic Drug Market Report by Segment (Unbranded Generics, Branded Generics), Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2024-2032

North Africa Generic Drug Market Report by Segment (Unbranded Generics, Branded Generics), Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A3280
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   North Africa Generic Drug Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Segment
    6.1    Unbranded Generics
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Branded Generics
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Therapy Area
    7.1   Central Nervous System
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cardiovascular
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Dermatology
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Genitourinary/Hormonal
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Respiratory
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Rheumatology
        7.6.1 Market Trends
        7.6.2 Market Forecast
    7.7    Diabetes
        7.7.1 Market Trends
        7.7.2 Market Forecast
    7.8    Oncology
        7.8.1 Market Trends
        7.8.2 Market Forecast
    7.9    Others
        7.9.1 Market Trends
        7.9.2 Market Forecast
8    Market Breakup by Drug Delivery
    8.1   Oral
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Injectables
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Dermal/Topical
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Inhalers
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Retail Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Hospital Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
10    Market Breakup by Country
    10.1    Algeria
        10.1.1 Market Trends
        10.1.2 Market Breakup by Segment
        10.1.3 Market Breakup by Therapy Area
        10.1.4 Market Breakup by Drug Delivery
        10.1.5 Market Breakup by Distribution Channel
        10.1.6 Market Forecast
    10.2    Egypt
        10.2.1 Market Trends
        10.2.2 Market Breakup by Segment
        10.2.3 Market Breakup by Therapy Area
        10.2.4 Market Breakup by Drug Delivery
        10.2.5 Market Breakup by Distribution Channel
        10.2.6 Market Forecast
    10.3    Libya
        10.3.1 Market Trends
        10.3.2 Market Breakup by Segment
        10.3.3 Market Breakup by Therapy Area
        10.3.4 Market Breakup by Drug Delivery
        10.3.5 Market Breakup by Distribution Channel
        10.3.6 Market Forecast
    10.4    Morocco
        10.4.1 Market Trends
        10.4.2 Market Breakup by Segment
        10.4.3 Market Breakup by Therapy Area
        10.4.4 Market Breakup by Drug Delivery
        10.4.5 Market Breakup by Distribution Channel
        10.4.6 Market Forecast
    10.5    Tunisia
        10.5.1 Market Trends
        10.5.2 Market Breakup by Segment
        10.5.3 Market Breakup by Therapy Area
        10.5.4 Market Breakup by Drug Delivery
        10.5.5 Market Breakup by Distribution Channel
        10.5.6 Market Forecast
    10.6    Others
        10.6.1 Market Trends
        10.6.2 Market Breakup by Segment
        10.6.3 Market Breakup by Therapy Area
        10.6.4 Market Breakup by Drug Delivery
        10.6.5 Market Breakup by Distribution Channel
        10.6.6 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Policy and Regulatory Landscape
16    Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players

List of Figures

Figure 1: North Africa: Generic Drug Market: Major Drivers and Challenges
Figure 2: North Africa: Generic Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 3: North Africa: Generic Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: North Africa: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 5: North Africa: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 6: North Africa: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 7: North Africa: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 8: North Africa: Generic Drug Market: Breakup by Country (in %), 2023
Figure 9: North Africa: Generic Drug (Unbranded Generics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: North Africa: Generic Drug (Unbranded Generics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: North Africa: Generic Drug (Branded Generics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: North Africa: Generic Drug (Branded Generics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: North Africa: Generic Drug (Central Nervous System) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: North Africa: Generic Drug (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: North Africa: Generic Drug (Cardiovascular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: North Africa: Generic Drug (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: North Africa: Generic Drug (Dermatology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: North Africa: Generic Drug (Dermatology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: North Africa: Generic Drug (Genitourinary/Hormonal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: North Africa: Generic Drug (Genitourinary/Hormonal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: North Africa: Generic Drug (Respiratory) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: North Africa: Generic Drug (Respiratory) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: North Africa: Generic Drug (Rheumatology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: North Africa: Generic Drug (Rheumatology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: North Africa: Generic Drug (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: North Africa: Generic Drug (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: North Africa: Generic Drug (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: North Africa: Generic Drug (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: North Africa: Generic Drug (Other Therapy Areas) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: North Africa: Generic Drug (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: North Africa: Generic Drug (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: North Africa: Generic Drug (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: North Africa: Generic Drug (Injectables) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: North Africa: Generic Drug (Injectables) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: North Africa: Generic Drug (Dermal/Topical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: North Africa: Generic Drug (Dermal/Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North Africa: Generic Drug (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North Africa: Generic Drug (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: North Africa: Generic Drug (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: North Africa: Generic Drug (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: North Africa: Generic Drug (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023 
Figure 42: North Africa: Generic Drug (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Algeria: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Algeria: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 45: Algeria: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 46: Algeria: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 47: Algeria: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 48: Algeria: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Egypt: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Egypt: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 51: Egypt: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 52: Egypt: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 53: Egypt: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 54: Egypt: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Libya: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Libya: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 57: Libya: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 58: Libya: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 59: Libya: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 60: Libya: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Morocco: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Morocco: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 63: Morocco: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 64: Morocco: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 65: Morocco: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 66: Morocco: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Tunisia: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Tunisia: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 69: Tunisia: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 70: Tunisia: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 71: Tunisia: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 72: Tunisia: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Generic Drug Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Generic Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: North Africa: Generic Drug Industry: SWOT Analysis
Figure 76: North Africa: Generic Drug Industry: Value Chain Analysis
Figure 77: North Africa: Generic Drug Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: North Africa: Generic Drug Market: Key Industry Highlights, 2023 and 2032
Table 2: North Africa: Generic Drug Market Forecast: Breakup by Segment (in Million US$), 2024-2032
Table 3: North Africa: Generic Drug Market Forecast: Breakup by Therapy Area (in Million US$), 2024-2032
Table 4: North Africa: Generic Drug Market Forecast: Breakup by Drug Delivery (in Million US$), 2024-2032
Table 5: North Africa: Generic Drug Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: North Africa: Generic Drug Market Forecast: Breakup by Country (in Million US$), 2024-2032
Table 7: North Africa: Generic Drug Market: Key Players

North Africa Generic Drug Market Report by Segment (Unbranded Generics, Branded Generics), Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More